Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting 17-09-2025, 03:30

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners 4-06-2024, 18:00

Plains All American Reports Fourth-Quarter and Full-Year 9-02-2023, 04:20